(Q71974488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

T Niwa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Katsuzaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

S Miyazaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Momoi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Akiba

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Miyazaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

K Nokura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

F Hayase

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

N Tatemichi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Y Takei

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

187-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1997.23

22 October 2019

exact match

0 references

cites work

A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Beta-2 microglobulin is an amyloidogenic protein in man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Crosslines A and B as candidates for the fluorophores in age- and diabetes- related cross-linked proteins, and the diacetates produced by Maillard reaction of a-N-acetyl-L-lysine with D-glucose.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Accelerated age-related browning of human collagen in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Hemoglobin-AGE: a circulating marker of advanced glycosylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.23

7 January 2021

Identifiers

DOI

10.1038/KI.1997.23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8995733%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference